References
- GlobocanEstimated cancer incidence, mortality and prevalence worldwide in 2012International Agency for Research on Cancer Available from: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspxAccessed April 3, 2017
- Cervical Cancer Overview Available from: http://www.nccc-online.org/hpvcervical-cancer/cervical-cancer-overview/Accessed April 4, 2017
- MehmetogluHCSadikogluGOzcakirABilgelNPap smear screening in the primary health care setting: a study from TurkeyN Am J Med Sci201021046747222558549
- JanerichDTHadjimichaelOSchwartzPEThe screening histories of women with invasive cervical cancer, ConnecticutAm J Public Health19958567917947762711
- RosePGBundyBNWatkinsEBConcurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancerN Engl J Med1999340151144115310202165
- SEER cancer incidence public use data base, 1973–1994Bethesda, MDNational Cancer Institute1997 software
- Cervical cancerNIH consensus statementNIH Office of Medical Applications of ResearchBethesda, MD, USA19961411516
- Duenas-GonzalezAZarbaJJPatelFPhase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervixJ Clin Oncol201129131678168521444871
- HockelMHornLCEinenkelJLaterally extended endopelvic resection: surgical treatment of locally advanced and recurrent cancer of the uterine cervix and vagina based on ontogenetic anatomyGynecol Oncol2012127229730222864112
- MonkBJSillMWMcMeekinDSPhase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group studyJ Clin Oncol2009274649465519720909
- TewariKSSillMWLongHJ3rdImproved survival with bevacizumab in advanced cervical cancerN Engl J Med2014370873474324552320
- CetinaLCrombetTJiménez-LimaRA pilot study of nimotuzumab plus single agent chemotherapy as second- or third-line treatment or more in patients with recurrent, persistent or metastatic cervical cancerCancer Biol Ther201516568468925802932
- ZighelboimIWrightJDGaoFMulticenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancerGynecol Oncol20131301646823591400
- DuFZhengZShiSS-1 and Cisplatin with or without nimotuzumab for patients with untreated unresectable or metastatic gastric cancer: a randomized, open-label phase 2 trialMedicine (Baltimore)20159423e95826061330
- LiuZGZhaoYTangJNimotuzumab combined with concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a retrospective analysisOncotarget2016717244292443527016412
- HertleinLLenhardMKirschenhoferACetuximab monotherapy in advanced cervical cancer: a retrospective study with five patientsArch Gynecol Obstet2011283110911320180130
- SantinADSillMWMcMeekinDSPhase II trial of cetuximab in the treatment of persistent or recurrent squamous or non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group studyGynecol Oncol2011122349550021684583
- JinTZhuYLuoJLProspective phase II trial of nimotuzumab in combination with radiotherapy and concurrent capecitabine in locally advanced rectal cancerInt J Colorectal Dis201530333734525564344